Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

612
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
612
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

472
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
472
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

677
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

674
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
674
Actuarial Approach01:20

Actuarial Approach

344
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
344
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

899
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
899

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-up.

Annals of internal medicine·2026
Same author

The 'Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease' (PATROL) study.

BJU international·2026
Same author

The clinical utility of prostate MRI before biopsy.

Nature reviews. Urology·2026
Same author

Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: an Evaluation of the COVID-19 Pandemic.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer.

Neoplasia (New York, N.Y.)·2026

相关实验视频

Updated: Mar 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

979

在间隔审查下估计最佳定制的主动监控策略.

Muxuan Liang1, Yingqi Zhao2, Daniel W Lin3

  • 1Department of Biostatistics, University of Florida, Gainesville, FL 32611, United States.

Biometrics
|May 30, 2025
PubMed
概括

积极监测 (AS) 提供了癌症手术的替代方案,但涉及侵入性活检. 这项研究引入了一种针对AS策略的新方法,减少了活检负担并改善了患者的治疗结果.

关键词:
癌症监测 癌症监测 癌症监测在决策过程中做出决定.概括错误是一般化的错误.时间间隔审查审查.缺失的数据 缺失的数据

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

3.2K

相关实验视频

Last Updated: Mar 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

979
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
15:00

Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies

Published on: February 3, 2023

3.2K

科学领域:

  • 生物统计学 生物统计学
  • 医疗信息学 医疗信息学
  • 癌症研究 癌症研究

背景情况:

  • 主动监测 (AS) 是一种癌症管理策略,涉及重复活检.
  • 活检是侵入性的,带有感染和出血等风险.
  • 当前的AS协议缺乏个别定制,导致不必要的程序.

研究的目的:

  • 开发一种用于估计定制的AS策略的方法.
  • 为了考虑AS研究中的间隔审查和患者脱而出.
  • 根据个体患者的风险和成本效益分析,优化AS强度.

主要方法:

  • 使用非参数的基于内核的方法来估计真正阳性率 (TPR) 和真负率 (TNR).
  • 开发了一个加权分类框架,以估计最佳定制的AS战略.
  • 该方法包括成本效益的成本效益比率.

主要成果:

  • 拟议的方法准确地估计TPR和TNR在存在间隔审查和脱学时.
  • 估计了一个最佳的AS策略,平衡TPR和TNR.
  • 该方法在模拟和前列腺癌研究中表现出优越性.

结论:

  • 拟议的方法为个性化癌症监测提供了一个统计严格的方法.
  • 这种技术可以减少AS的侵入性活检的负担.
  • 它可以使更具成本效益和个性化的癌症护理决策.